(Q37088884)

18 August 2017

1 reference

title

Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression (English)

1 reference

18 August 2017

1 reference

Marc A Dall'Era

1

1 reference

18 August 2017

Badrinath R Konety

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

19 February 2008

1 reference

18 August 2017

published in

Nature Reviews Urology

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

277-283

1 reference

Active surveillance with selective delayed intervention for favorable risk prostate cancer.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Natural History of Early, Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Geographic pathology of latent prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Cancer of the Prostate in Men Less than 50 Years Old: An Analysis of 51 Cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Incidence of prostatic carcinoma in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Increased accuracy of biopsy Gleason score obtained by extended needle biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Nomogram use for the prediction of indolent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Urologic imaging for localized prostate cancer in 2007.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Early outcomes of active surveillance for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Uncertainty and Quality of Life of Older Men Who Undergo Watchful Waiting for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Uncertainty intervention for watchful waiting in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Intensive lifestyle changes may affect the progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1058

7 January 2021

Identifiers

DOI

10.1038/NCPURO1058

1 reference

18 August 2017

1 reference